Besivance Suspension
Product Images NDC 82260-466

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Besivance (NDC 82260-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Americas Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (964c5a85 3cc2 4d53 Ab7d F8d205d997e4 01)

FDA Label Image

Carton (Carton)

Carton (Carton)
This is a description of Besifloxacin Ophthalmic Suspension 0.6%. It contains besifloxacin as the active ingredient and benzalkonium chloride as a preservative. The suspension is distributed by Bausch & Lomb Americas Inc. and manufactured by Bausch & Lomb Incorporated. The usual dosage is one drop in the affected eye(s) three times a day for 7 days. The product should be stored between 15°C to 25°C and protected from light. It is important to shake the closed bottle before use. This ophthalmic suspension is for topical use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.